SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-084483
Filing Date
2023-03-30
Accepted
2023-03-30 07:02:00
Documents
12
Period of Report
2023-03-30
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d479867d8k.htm   iXBRL 8-K 32217
  Complete submission text file 0001193125-23-084483.txt   157179

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rna-20230330.xsd EX-101.SCH 2881
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rna-20230330_lab.xml EX-101.LAB 17995
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rna-20230330_pre.xml EX-101.PRE 11283
6 EXTRACTED XBRL INSTANCE DOCUMENT d479867d8k_htm.xml XML 3410
Mailing Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121
Business Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121 858-401-7900
Avidity Biosciences, Inc. (Filer) CIK: 0001599901 (see all company filings)

IRS No.: 461336960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39321 | Film No.: 23777124
SIC: 2834 Pharmaceutical Preparations